Ketazed (Ketotifen Hydrogen Fumarate)

Ketotifen hydrogen fumarate blocks histamine H1 receptors on the eye and stabilises mast cells, preventing the release of histamine and other inflammatory mediators. This dual action reduces vascular leakage, swelling and nerve irritation that cause allergy‑related eye symptoms.

The dosing regimen is determined by the prescribing clinician. Typically, one drop is instilled in each affected eye two to four times daily, but the exact frequency and duration should follow the prescriber’s instructions.

Safety data for ketotifen hydrogen fumarate in pregnancy and lactation are limited. Women who are pregnant, planning pregnancy, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Ketazed.

To order Ketazed, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Ketazed combines antihistamine and mast‑cell‑stabilising actions, offering both immediate symptom relief and longer‑term control. Compared with single‑action antihistamine drops (e.g., olopatadine) or purely anti‑inflammatory steroids, Ketazed provides a broader mechanism without the steroid‑related risk of intra‑ocular pressure rise.

Ketazed should be stored at room temperature, below 25 °C, in its original container. Keep the bottle tightly closed, protect it from direct light and moisture, and discard any product that appears discoloured or contaminated.

Tilt the head back slightly, pull down the lower eyelid to create a small pocket, and instil the prescribed number of drops into the conjunctival sac. Close the eye gently for a few seconds and avoid blinking excessively. Do not touch the dropper tip to any surface.

Serious adverse events, although rare, include severe eye pain, sudden vision changes, corneal ulceration, marked swelling of the eyelids, and systemic allergic reactions such as anaphylaxis. If any of these occur, discontinue use and seek immediate medical attention.

Ketazed should not be used by individuals with a known hypersensitivity to ketotifen hydrogen fumarate or any of the formulation excipients. Persons with active ocular infections or severe ocular surface disease should consult an eye‑care professional before initiating therapy.